Global Genotyping Market to Reach $38.7 Billion by 2030
The global market for Genotyping estimated at US$12.3 Billion in the year 2022, is projected to reach a revised size of US$38.7 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2022-2030. Polymerase Chain Reaction (PCR), one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$9.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sequencing segment is readjusted to a revised 16.6% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 14.3% CAGR
The Genotyping market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.1% and 13.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11% CAGR.Select Competitors (Total 39 Featured) -
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Beckman Coulter, Inc.
- Fluidigm Corporation
- GE Healthcare
- Illumina, Inc.
- Life Technologies Corporation
- Qiagen NV
- Roche Diagnostics
- Sequenom, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Genotyping - A Prelude
- Increasing Incidence of Genetic Diseases Propels the Genotyping Assays Market
- Which Genotyping Techniques Can be Adopted???
- Genotyping - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
3. MARKET TRENDS & DRIVERS
- SEQUENCING TECHNOLOGIES TAKE THE MAJOR MARKET SHARE
- Expanding Applications of DNA Sequencing Offer Significant Opportunities for the Genotyping Market
- Decline in DNA Sequencing Costs Boosts Market Expansion
- The Race for $100 Genome Gets Closer
- Rising Demand for Hybrid Capture-Based Next Generation Sequencing
- Use of Genotyping in Drug Development Drives Market Opportunities
- Growth in Adoption of Plant and Animal Sequencing in Agricultural Research
- A Peek into the Genome Sequencing Projects
- GENOTYPING REAGENTS DOMINATE THE MARKET BY PRODUCT TYPE
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Genotyping Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 2: World Recent Past, Current & Future Analysis for Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 3: World 8-Year Perspective for Genotyping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World 8-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 6: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 7: World 8-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 8: World Recent Past, Current & Future Analysis for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 9: World 8-Year Perspective for Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World 8-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 12: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 13: World 8-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 15: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 17: World 8-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 18: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 19: World 8-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 21: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Diagnostics & Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 23: World 8-Year Perspective for Diagnostics & Personalized Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 24: World Recent Past, Current & Future Analysis for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 25: World 8-Year Perspective for Pharmacogenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 26: World Recent Past, Current & Future Analysis for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 27: World 8-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 28: World Recent Past, Current & Future Analysis for Animal Genetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 29: World 8-Year Perspective for Animal Genetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 30: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 31: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
UNITED STATES
- Genotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 32: USA Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: USA 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 34: USA Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 35: USA 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 36: USA Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 37: USA 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
CANADA
- Table 38: Canada Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Canada 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 40: Canada Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 41: Canada 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 42: Canada Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 43: Canada 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
JAPAN
- Genotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 44: Japan Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: Japan 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 46: Japan Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 47: Japan 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 48: Japan Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 49: Japan 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
CHINA
- Genotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 50: China Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: China 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 52: China Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 53: China 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 54: China Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 55: China 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
EUROPE
- Genotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 56: Europe Recent Past, Current & Future Analysis for Genotyping by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 57: Europe 8-Year Perspective for Genotyping by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
- Table 58: Europe Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 59: Europe 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 60: Europe Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 61: Europe 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 62: Europe Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: Europe 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
FRANCE
- Genotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 64: France Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 65: France 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 66: France Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 67: France 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 68: France Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: France 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
GERMANY
- Genotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 70: Germany Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 71: Germany 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 72: Germany Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 73: Germany 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 74: Germany Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: Germany 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
ITALY
- Table 76: Italy Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 77: Italy 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 78: Italy Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 79: Italy 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 80: Italy Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: Italy 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
UNITED KINGDOM
- Genotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 82: UK Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 83: UK 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 84: UK Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 85: UK 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 86: UK Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 87: UK 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
REST OF EUROPE
- Table 88: Rest of Europe Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 89: Rest of Europe 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 90: Rest of Europe Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 91: Rest of Europe 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 92: Rest of Europe Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: Rest of Europe 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
ASIA-PACIFIC
- Genotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 94: Asia-Pacific Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 95: Asia-Pacific 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 96: Asia-Pacific Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 97: Asia-Pacific 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: Asia-Pacific 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
REST OF WORLD
- Table 100: Rest of World Recent Past, Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 101: Rest of World 8-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, Capillary Electrophoresis, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
- Table 102: Rest of World Recent Past, Current & Future Analysis for Genotyping by Product - Reagents & Kits, Software & Services and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 103: Rest of World 8-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Software & Services and Instruments for the Years 2023 & 2030
- Table 104: Rest of World Recent Past, Current & Future Analysis for Genotyping by Application - Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 105: Rest of World 8-Year Perspective for Genotyping by Application - Percentage Breakdown of Value Sales for Diagnostics & Personalized Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics and Other Applications for the Years 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Beckman Coulter, Inc.
- Fluidigm Corporation
- GE Healthcare
- Illumina, Inc.
- Life Technologies Corporation
- Qiagen NV
- Roche Diagnostics
- Sequenom, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 12.3 Billion |
| Forecasted Market Value ( USD | $ 38.7 Billion |
| Compound Annual Growth Rate | 15.4% |
| Regions Covered | Global |
